References
Christophi GP, Rong R, Holtzapple PG, Massa PT, Landas SK (2012) Immune markers and differential signaling networks in ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis 18:2342–2356. https://doi.org/10.1002/ibd.22957
Derkinderen P, Neunlist M (2018) Crohn’s and Parkinson disease: is LRRK2 lurking around the corner? Nat Rev Gastroenterol Hepatol. https://doi.org/10.1038/s41575-018-0006-9
Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H et al (2013) Colonic inflammation in Parkinson’s disease. Neurobiol Dis 50:42–48. https://doi.org/10.1016/j.nbd.2012.09.007
Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N et al (2018) Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2018.0605
Schwiertz A, Spiegel J, Dillmann U, Grundmann D, Bürmann J, Faßbender K et al (2018) Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson’s disease. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2018.02.022
Stolzenberg E, Berry D, Yang D, Lee EY, Kroemer A, Kaufman S et al (2017) A Role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun 9:456–463. https://doi.org/10.1159/000477990
Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T (2018) Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014. Gut. https://doi.org/10.1136/gutjnl-2017-315666
Acknowledgements
This work was supported by a grant from centre d’entraide et de coordination des associations de parkinsoniens (CECAP) and Parkinsonien de Vendée (FFGP) to AP and PD and Institut de France to PD.
Author information
Authors and Affiliations
Contributions
AP, AL, ED, GC and MRD performed the experiments. AB, ED, MN and MRD were involved in tissue sampling and biobanking. MRD and PD supervised the study, wrote the first draft and the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no actual or potential conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Prigent, A., Lionnet, A., Durieu, E. et al. Enteric alpha-synuclein expression is increased in Crohn’s disease. Acta Neuropathol 137, 359–361 (2019). https://doi.org/10.1007/s00401-018-1943-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-018-1943-7